Reporting Segmentarrow_drop_down Product Line Amount (USD) Percentage
keyboard_arrow_right Reporting Segment & Product Line Amount (USD) Percentage
Cell Therapies & Specialty Biologics
Biologically-Derived Tissue Scaffolding Products; private insurance
These companies manufacture tissue scaffolding products, primarily from placental tissue (such as amniotic membrane allografts) and sell directly to their customers. These are used for skin wound healing and dermal reconstruction. Their products are paid for primarily through private health insurance.
197.52M 100.00%
Cell Therapies & Specialty Biologics
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
Non-Attributed
Non-Attributed help Why Zero? Explanation of what the heck's going on here.
keyboard_arrow_right keyboard_arrow_down
Cell Therapies & Specialty Biologics
Biologically-Derived Tissue Scaffolding Products; private insurance
197.52M 100.00%
keyboard_arrow_right
These companies manufacture tissue scaffolding products, primarily from placental tissue (such as amniotic membrane allografts) and sell directly to their customers. These are used for skin wound healing and dermal reconstruction. Their products are paid for primarily through private health insurance.
keyboard_arrow_right keyboard_arrow_down
Cell Therapies & Specialty Biologics
Pre-Revenue Pharmaceuticals
Non-Attributed
Non-Attributed help Why Zero? Explanation of what the heck's going on here.
keyboard_arrow_right
help Why Zero? Explanation of what the heck's going on here.
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.